APO RESEARCH · REPORT
Peptide Synthesis
Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
Product & engineering
Understand the product.
Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
Selected research
Industry Growth & Trends
Global Peptide Synthesis Industry Growth and Trends Forecast to 2032
Market perspective
Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
Global Peptide Synthesis key players include Bachem, PolyPeptide, USV Peptides, Thermofischer, GL Biochem etc.
Europe is the largest market, with a share over 30%, followed by North America and Asia-Pacific, both have a share over 50% percent.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Peptide Synthesis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Peptide Synthesis market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peptide Synthesis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peptide Synthesis.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Peptide Synthesis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Peptide Synthesis Market by Company
Bachem
PolyPeptide
USV Peptides
Thermofischer
GL Biochem
Hybio
Bio Basic
JPT
Genscript
Xinbang
ScinoPharm
21st Century Bio
CPC Scientific
LifeTein
AnaSpec
New England Peptide
Biomatik
Proimmune
Peptide Synthesis Segment by Type
CRO Peptides
CMO Peptides
Generic API Peptides
Peptide Synthesis Segment by Application
Commercial
Academic Research
Peptide Synthesis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Synthesis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Synthesis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Peptide Synthesis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- CRO Peptides
- CMO Peptides
- Generic API Peptides
Applications
- Commercial
- Academic Research
Companies covered
- Bachem
- PolyPeptide
- USV Peptides
- Thermofischer
- GL Biochem
- Hybio
- Bio Basic
- JPT
- Genscript
- Xinbang
- ScinoPharm
- 21st Century Bio
- CPC Scientific
- LifeTein
- AnaSpec
- New England Peptide
- Biomatik
- Proimmune
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Peptide Synthesis Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Peptide Synthesis Sales Estimates and Forecasts (2021-2032)
- 1.3 Peptide Synthesis Market by Type
- 1.3.1 CRO Peptides
- 1.3.2 CMO Peptides
- 1.3.3 Generic API Peptides
- 1.4 Global Peptide Synthesis Market Size by Type
- 1.4.1 Global Peptide Synthesis Market Size Overview by Type (2021-2032)
- 1.4.2 Global Peptide Synthesis Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Peptide Synthesis Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Peptide Synthesis Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Peptide Synthesis Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Peptide Synthesis Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Peptide Synthesis Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Peptide Synthesis Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Peptide Synthesis Industry Trends
- 2.2 Peptide Synthesis Industry Drivers
- 2.3 Peptide Synthesis Industry Opportunities and Challenges
- 2.4 Peptide Synthesis Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Peptide Synthesis Revenue (2021-2026)
- 3.2 Global Top Players by Peptide Synthesis Sales (2021-2026)
- 3.3 Global Top Players by Peptide Synthesis Price (2021-2026)
- 3.4 Global Peptide Synthesis Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Peptide Synthesis Major Company Production Sites & Headquarters
- 3.6 Global Peptide Synthesis Company, Product Type & Application
- 3.7 Global Peptide Synthesis Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Peptide Synthesis Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Peptide Synthesis Players Market Share by Revenue in 2025
- 3.8.3 2025 Peptide Synthesis Tier 1, Tier 2, and Tier 3
4 Peptide Synthesis Regional Status and Outlook
- 4.1 Global Peptide Synthesis Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Peptide Synthesis Historic Market Size by Region
- 4.2.1 Global Peptide Synthesis Sales in Volume by Region (2021-2026)
- 4.2.2 Global Peptide Synthesis Sales in Value by Region (2021-2026)
- 4.2.3 Global Peptide Synthesis Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Peptide Synthesis Forecasted Market Size by Region
- 4.3.1 Global Peptide Synthesis Sales in Volume by Region (2027-2032)
- 4.3.2 Global Peptide Synthesis Sales in Value by Region (2027-2032)
- 4.3.3 Global Peptide Synthesis Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Peptide Synthesis by Application
- 5.1 Peptide Synthesis Market by Application
- 5.1.1 Commercial
- 5.1.2 Academic Research
- 5.2 Global Peptide Synthesis Market Size by Application
- 5.2.1 Global Peptide Synthesis Market Size Overview by Application (2021-2032)
- 5.2.2 Global Peptide Synthesis Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Peptide Synthesis Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Peptide Synthesis Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Peptide Synthesis Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Peptide Synthesis Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Peptide Synthesis Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Peptide Synthesis Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Bachem
- 6.1.1 Bachem Company Information
- 6.1.2 Bachem Business Overview
- 6.1.3 Bachem Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Bachem Peptide Synthesis Product Portfolio
- 6.1.5 Bachem Recent Developments
- 6.2 PolyPeptide
- 6.2.1 PolyPeptide Company Information
- 6.2.2 PolyPeptide Business Overview
- 6.2.3 PolyPeptide Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 PolyPeptide Peptide Synthesis Product Portfolio
- 6.2.5 PolyPeptide Recent Developments
- 6.3 USV Peptides
- 6.3.1 USV Peptides Company Information
- 6.3.2 USV Peptides Business Overview
- 6.3.3 USV Peptides Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 USV Peptides Peptide Synthesis Product Portfolio
- 6.3.5 USV Peptides Recent Developments
- 6.4 Thermofischer
- 6.4.1 Thermofischer Company Information
- 6.4.2 Thermofischer Business Overview
- 6.4.3 Thermofischer Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Thermofischer Peptide Synthesis Product Portfolio
- 6.4.5 Thermofischer Recent Developments
- 6.5 GL Biochem
- 6.5.1 GL Biochem Company Information
- 6.5.2 GL Biochem Business Overview
- 6.5.3 GL Biochem Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 GL Biochem Peptide Synthesis Product Portfolio
- 6.5.5 GL Biochem Recent Developments
- 6.6 Hybio
- 6.6.1 Hybio Company Information
- 6.6.2 Hybio Business Overview
- 6.6.3 Hybio Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Hybio Peptide Synthesis Product Portfolio
- 6.6.5 Hybio Recent Developments
- 6.7 Bio Basic
- 6.7.1 Bio Basic Company Information
- 6.7.2 Bio Basic Business Overview
- 6.7.3 Bio Basic Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Bio Basic Peptide Synthesis Product Portfolio
- 6.7.5 Bio Basic Recent Developments
- 6.8 JPT
- 6.8.1 JPT Company Information
- 6.8.2 JPT Business Overview
- 6.8.3 JPT Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 JPT Peptide Synthesis Product Portfolio
- 6.8.5 JPT Recent Developments
- 6.9 Genscript
- 6.9.1 Genscript Company Information
- 6.9.2 Genscript Business Overview
- 6.9.3 Genscript Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Genscript Peptide Synthesis Product Portfolio
- 6.9.5 Genscript Recent Developments
- 6.10 Xinbang
- 6.10.1 Xinbang Company Information
- 6.10.2 Xinbang Business Overview
- 6.10.3 Xinbang Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Xinbang Peptide Synthesis Product Portfolio
- 6.10.5 Xinbang Recent Developments
- 6.11 ScinoPharm
- 6.11.1 ScinoPharm Company Information
- 6.11.2 ScinoPharm Business Overview
- 6.11.3 ScinoPharm Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 ScinoPharm Peptide Synthesis Product Portfolio
- 6.11.5 ScinoPharm Recent Developments
- 6.12 21st Century Bio
- 6.12.1 21st Century Bio Company Information
- 6.12.2 21st Century Bio Business Overview
- 6.12.3 21st Century Bio Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 21st Century Bio Peptide Synthesis Product Portfolio
- 6.12.5 21st Century Bio Recent Developments
- 6.13 CPC Scientific
- 6.13.1 CPC Scientific Company Information
- 6.13.2 CPC Scientific Business Overview
- 6.13.3 CPC Scientific Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 CPC Scientific Peptide Synthesis Product Portfolio
- 6.13.5 CPC Scientific Recent Developments
- 6.14 LifeTein
- 6.14.1 LifeTein Company Information
- 6.14.2 LifeTein Business Overview
- 6.14.3 LifeTein Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 LifeTein Peptide Synthesis Product Portfolio
- 6.14.5 LifeTein Recent Developments
- 6.15 AnaSpec
- 6.15.1 AnaSpec Company Information
- 6.15.2 AnaSpec Business Overview
- 6.15.3 AnaSpec Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 AnaSpec Peptide Synthesis Product Portfolio
- 6.15.5 AnaSpec Recent Developments
- 6.16 New England Peptide
- 6.16.1 New England Peptide Company Information
- 6.16.2 New England Peptide Business Overview
- 6.16.3 New England Peptide Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 New England Peptide Peptide Synthesis Product Portfolio
- 6.16.5 New England Peptide Recent Developments
- 6.17 Biomatik
- 6.17.1 Biomatik Company Information
- 6.17.2 Biomatik Business Overview
- 6.17.3 Biomatik Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Biomatik Peptide Synthesis Product Portfolio
- 6.17.5 Biomatik Recent Developments
- 6.18 Proimmune
- 6.18.1 Proimmune Company Information
- 6.18.2 Proimmune Business Overview
- 6.18.3 Proimmune Peptide Synthesis Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Proimmune Peptide Synthesis Product Portfolio
- 6.18.5 Proimmune Recent Developments
7 North America by Country
- 7.1 North America Peptide Synthesis Sales by Country
- 7.1.1 North America Peptide Synthesis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Peptide Synthesis Sales by Country (2021-2026)
- 7.1.3 North America Peptide Synthesis Sales Forecast by Country (2027-2032)
- 7.2 North America Peptide Synthesis Market Size by Country
- 7.2.1 North America Peptide Synthesis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Peptide Synthesis Market Size by Country (2021-2026)
- 7.2.3 North America Peptide Synthesis Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Peptide Synthesis Sales by Country
- 8.1.1 Europe Peptide Synthesis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Peptide Synthesis Sales by Country (2021-2026)
- 8.1.3 Europe Peptide Synthesis Sales Forecast by Country (2027-2032)
- 8.2 Europe Peptide Synthesis Market Size by Country
- 8.2.1 Europe Peptide Synthesis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Peptide Synthesis Market Size by Country (2021-2026)
- 8.2.3 Europe Peptide Synthesis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Peptide Synthesis Sales by Country
- 9.1.1 Asia-Pacific Peptide Synthesis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Peptide Synthesis Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Peptide Synthesis Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Peptide Synthesis Market Size by Country
- 9.2.1 Asia-Pacific Peptide Synthesis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Peptide Synthesis Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Peptide Synthesis Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Peptide Synthesis Sales by Country
- 10.1.1 South America Peptide Synthesis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Peptide Synthesis Sales by Country (2021-2026)
- 10.1.3 South America Peptide Synthesis Sales Forecast by Country (2027-2032)
- 10.2 South America Peptide Synthesis Market Size by Country
- 10.2.1 South America Peptide Synthesis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Peptide Synthesis Market Size by Country (2021-2026)
- 10.2.3 South America Peptide Synthesis Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Peptide Synthesis Sales by Country
- 11.1.1 Middle East and Africa Peptide Synthesis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Peptide Synthesis Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Peptide Synthesis Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Peptide Synthesis Market Size by Country
- 11.2.1 Middle East and Africa Peptide Synthesis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Peptide Synthesis Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Peptide Synthesis Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Peptide Synthesis Value Chain Analysis
- 12.1.1 Peptide Synthesis Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Peptide Synthesis Production Mode & Process
- 12.2 Peptide Synthesis Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Peptide Synthesis Distributors
- 12.2.3 Peptide Synthesis Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst